20/20 Biolabs, Inc. (AIDX)Healthcare | Medical Devices | Gaithersburg, United States | NasdaqCM
1.78 USD
+0.06
(3.790%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.77 -0.01 (-0.006%) ⇩ (April 17, 2026, 7:56 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:53 a.m. EDT
Sell. AIDX is a distressed biotech stock trading at a 50% discount to its technical averages but fundamentally insolvent with a current ratio of 0.597, net losses of $634k in free cash flow, and negative earnings. The lack of dividends and negative total returns make it uninvestable on any metric other than a speculative recovery. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.415 |
| Market Cap | 18,654,558 |
| Profit Margins | -182.82% |
| Previous Name | 20/20 GeneSystems Inc. |
| Website | https://2020biolabs.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9253669 |
| Address1 | 15,810 Gaither Road |
| Address2 | Suite 235 |
| All Time High | 50.0 |
| All Time Low | 1.51 |
| Ask | 1.74 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 80,190 |
| Average Daily Volume3 Month | 314,968 |
| Average Volume | 314,968 |
| Average Volume10Days | 80,190 |
| Bid | 1.64 |
| Bid Size | 1 |
| Book Value | -0.012 |
| City | Gaithersburg |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.78 |
| Current Ratio | 0.597 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.85 |
| Day Low | 1.72 |
| Display Name | 20/20 Biolabs |
| Ebitda | -3,245,114 |
| Ebitda Margins | -1.58675 |
| Enterprise To Ebitda | -5.845 |
| Enterprise To Revenue | 9.275 |
| Enterprise Value | 18,968,294 |
| Eps Trailing Twelve Months | -0.36 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.525122 |
| Fifty Day Average Change | -1.745122 |
| Fifty Day Average Change Percent | -0.49505293 |
| Fifty Two Week Change Percent | -92.53669 |
| Fifty Two Week High | 50.0 |
| Fifty Two Week High Change | -48.22 |
| Fifty Two Week High Change Percent | -0.96440005 |
| Fifty Two Week Low | 1.51 |
| Fifty Two Week Low Change | 0.26999998 |
| Fifty Two Week Low Change Percent | 0.17880793 |
| Fifty Two Week Range | 1.51 - 50.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,771,511,400,000 |
| Float Shares | 9,017,600 |
| Free Cashflow | -634,027 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.2956 |
| Gross Profits | 604,541 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.30337 |
| Held Percent Institutions | 0.000010000001 |
| Implied Shares Outstanding | 10,480,089 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,026-02-19 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland. |
| Long Name | 20/20 Biolabs, Inc. |
| Market | us_market |
| Market Cap | 18,654,558 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_7685164 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -3,738,821 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 18,444,956 |
| Open | 1.79 |
| Operating Cashflow | -1,919,720 |
| Operating Margins | -1.6958799 |
| Payout Ratio | 0.0 |
| Phone | (240) 453-6339 |
| Post Market Change | -0.0059999228 |
| Post Market Change Percent | -0.3370743 |
| Post Market Price | 1.774 |
| Post Market Time | 1,776,470,173 |
| Prev Name | 20/20 GeneSystems Inc. |
| Previous Close | 1.715 |
| Price Hint | 4 |
| Price To Book | -148.33333 |
| Price To Sales Trailing12 Months | 9.12144 |
| Profit Margins | -1.8281599 |
| Quick Ratio | 0.498 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0649999 |
| Regular Market Change Percent | 3.79008 |
| Regular Market Day High | 1.85 |
| Regular Market Day Low | 1.72 |
| Regular Market Day Range | 1.72 - 1.85 |
| Regular Market Open | 1.79 |
| Regular Market Previous Close | 1.715 |
| Regular Market Price | 1.78 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 95,758 |
| Return On Assets | -0.5392 |
| Return On Equity | -5.03119 |
| Revenue Growth | 0.004 |
| Revenue Per Share | 0.415 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 10,480,089 |
| Shares Percent Shares Out | 0.0052 |
| Shares Short | 54,248 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 105,708 |
| Short Name | 20/20 Biolabs, Inc. |
| Short Percent Of Float | 0.0064999997 |
| Short Ratio | 0.15 |
| Source Interval | 15 |
| State | MD |
| Symbol | AIDX |
| Total Cash | 1,025,987 |
| Total Cash Per Share | 0.098 |
| Total Debt | 1,358,639 |
| Total Revenue | 2,045,133 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.36 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.525122 |
| Two Hundred Day Average Change | -1.745122 |
| Two Hundred Day Average Change Percent | -0.49505293 |
| Type Disp | Equity |
| Volume | 95,758 |
| Website | https://2020biolabs.com |
| Zip | 20,877 |